Curis Lifesciences
add_icon

Curis Lifesciences

99.00
+1.00
(1.02%)
Market Cap
80.04 Cr
PE Ratio
14.78
Volume
7,000.00
Day High - Low
100.00 - 99.00
52W High-Low
147.90 - 96.95
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
80.04 Cr
EPS
10.29
PE Ratio
14.78
PB Ratio
2.12
Book Value
54.11
EBITDA
10.00
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
37.62
Debt to Equity
1.48
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,724.40
#1 4,13,741.32
37.53
#1 54,729.00
9.71
#1 10,980
16.07
58.16
6,291.00
1,67,006.28
67.40
9,712.00
18.67
2,191
-1.02
53.89
4,241.70
1,43,558.40
62.90
11,539.40
6.99
1,911
26.24
66.58
1,341.10
1,08,330.28
23.68
28,409.50
7.12
5,291
-57.18
43.41
1,280.40
1,06,866.07
19.34
33,741.20
16.73
5,725
-15.28
60.10
2,219.40
1,01,381.93
21.81
22,909.50
13.74
3,306
#1 37.44
57.52
900.75
90,636.53
#1 18.06
23,511.00
18.55
4,615
-0.32
49.52
2,024.30
83,564.13
46.65
12,744.20
#1 20.90
2,007
7.65
38.95
1,158.80
67,303.29
19.60
32,345.60
9.43
3,484
7.59
47.48
5,392.00
64,469.45
26.53
13,458.30
3.70
2,216
1.90
37.57

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
38.16 %
Net Income Growth
12.96 %
Cash Flow Change
-728.57 %
ROE
-60.11 %
ROCE
-29.27 %
EBITDA Margin (Avg.)
-16.98 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Revenue
9
Expenses
6
EBITDA
3
Operating Profit %
30 %
Depreciation
0
Interest
0
Profit Before Tax
2
Tax
1
Net Profit
1
EPS in ₹
24.00

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
27
30
34
43
Fixed Assets
12
12
12
11
Current Assets
15
17
22
31
Capital Work in Progress
0
0
0
0
Investments
0
0
0
0
Other Assets
15
18
22
32
Total Liabilities
27
30
34
43
Current Liabilities
16
19
19
18
Non Current Liabilities
13
10
10
9
Total Equity
-1
0
6
16
Reserve & Surplus
-1
-0
5
10
Share Capital
1
1
1
6

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
0
0
-0
Investing Activities
-0
-1
-0
0
Operating Activities
5
3
0
-2
Financing Activities
-5
-3
0
2

Share Holding

% Holding
Dec 2024
Jun 2025
Oct 2025
Nov 2025
Promoter
92.68 %
92.68 %
92.68 %
68.03 %
FIIs
0.00 %
0.00 %
0.00 %
2.93 %
DIIs
0.00 %
0.00 %
0.00 %
10.86 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
4.37 %
0.00 %
0.00 %
13.97 %
Others
2.95 %
7.32 %
7.32 %
4.20 %
No of Share Holders
27
35
36
36

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
04 Dec 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Dec 2025 131.30 119.10

Technical Indicators

RSI(14)
Neutral
32.11
ATR(14)
Volatile
4.02
STOCH(9,6)
Neutral
35.16
STOCH RSI(14)
Neutral
47.98
MACD(12,26)
Bullish
0.01
ADX(14)
Strong Trend
29.25
UO(9)
Bearish
40.75
ROC(12)
Downtrend And Accelerating
-6.31
WillR(14)
Oversold
-92.53